Recording: Beyond the hype - Is it prime time for biomarkers in bladder cancer?
This recording will explore the evolving role of biomarkers in bladder cancer management. As the second addition to the webinar series “New frontiers in bladder cancer”, it will focus on how advances in biomarker research are supporting more precise diagnosis, risk stratification, and follow-up strategies.
| Organiser | European School of Urology (ESU) |
|---|---|
| CME | Not approved |
| Duration | Approx. 65 minutes |
The recording will begin by addressing the fundamental balance between sensitivity and specificity, including the role of tissue-based markers. The experts will examine the clinical application of urinary biomarkers in diagnosis, prognosis, and surveillance. In addition, they will discuss emerging blood-based approaches, with a particular focus on ctDNA in high-risk non-muscle-invasive bladder cancer (NMIBC).
The recording will highlight the strengths and limitations of each approach, as well as their potential to support informed clinical decision-making.
Speakers:
- Prof. Dr. M. Burger (GE)
- Dr. L.S. Mertens (NL)
- Prof. Dr. F. Liedberg (SE)
- Dr. L. Bukavina (US)
This recording is brought to you in collaboration with the EAU Section of Oncological Urology.
Review already released episodes of the series "New frontiers in bladder cancer":
- Ep. 1, 2026: "Bladder preservation: A changing paradigm in treatment"
Acknowledgement
This activity is supported by an educational grant from our industry partner, with no involvement in the programme or speaker selection.